IRLAB Therapeutics: IRLAB Nominates New Candidate Drug, IRL7

GOTHENBURG, SWEDEN / ACCESSWIRE / March 21, 2022 / IRLAB Therapeutics (STO:IRLAB-A) (FRA:6IRA)IRLAB (Nasdaq Stockholm: IRLAB A) takes important steps expanding the development pipeline and nominates a

Related Keywords

Stockholm , Sweden , Gothenburg , Vastra Gotalands Lan , Joakim Tedroff , , Nasdaq Stockholm , Nicholas Waters , Integrative Screening Process , Noirlab , Herapeutics , Nominates , Candidate , Drug , Rl757 , Treat , Apathy , Neurological , Disorders ,